fructose-1,6-diphosphate has been researched along with Coronary Heart Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (69.23) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pasque, MK; Wechsler, AS | 1 |
| Balashov, VP; Gatsura, VV; Kostin, IaV; Sedova, DG; Sernov, LN | 1 |
| Brumley, MA; Figueroa, A; Lehan, PH; Markov, AK; Skelton, TN | 1 |
| Boraso, A; Cargnoni, A; Comini, L; Condorelli, E; De Giuli, F; Ferrari, R; Pasini, E | 1 |
| Gatsura, VV; Rozonov, IuB; Sernov, LN; Shal'neva, TV; Snegireva, GV; Sokolova, OA | 1 |
| Fiori, G; Nicrosini, S; Pasotti, C | 1 |
| Barzizza, F; Finardi, G; Grandi, AM; Muggia, C; Venco, A | 1 |
| Malusardi, R; Manzi, G; Oddone, A; Orlandi, M | 1 |
| Di Bari, M; Fattirolli, F; Ferrucci, L; Marchionni, N; Moschi, G; Paoletti, M; Salani, B | 1 |
| Forrester, T; Ma, WS; Zhang, FM; Zhang, JN | 1 |
| Lureti, FG; Poggi Longostrevi, G | 1 |
| Amatuni, GV; Badalian, GO; Episkoposian, NG | 1 |
| Markov, AK | 1 |
1 review(s) available for fructose-1,6-diphosphate and Coronary Heart Disease
| Article | Year |
|---|---|
Metabolic intervention to affect myocardial recovery following ischemia.
Topics: Adenine; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Aminoimidazole Carboxamide; Animals; Citric Acid Cycle; Coronary Circulation; Coronary Disease; Fructosediphosphates; Glucose; Glycogen; Heart; Humans; Inosine; Myocardium; Oxidative Phosphorylation; Ribonucleosides; Ribose | 1984 |
3 trial(s) available for fructose-1,6-diphosphate and Coronary Heart Disease
| Article | Year |
|---|---|
[Effects of fructose-1,6-diphosphate in patients with chronic ischemic heart disease. Echocardiographic study].
Topics: Adult; Aged; Chronic Disease; Coronary Disease; Echocardiography; Female; Fructosediphosphates; Hexosediphosphates; Humans; Male; Middle Aged | 1989 |
Improved left ventricular function after short-term treatment with fructose-1,6-diphosphate: echocardiographic study in chronic ischemic heart disease and idiopathic dilated cardiomyopathy.
Topics: Aged; Cardiomegaly; Cardiomyopathy, Dilated; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Echocardiography; Female; Fructosediphosphates; Heart; Heart Ventricles; Hexosediphosphates; Humans; Male; Middle Aged | 1988 |
Improved exercise tolerance by i.v. fructose-1,6-diphosphate in chronic, stable angina pectoris.
Topics: Aged; Angina Pectoris; Chronic Disease; Coronary Disease; Exercise; Female; Fructosediphosphates; Heart Rate; Hemodynamics; Hexosediphosphates; Humans; Injections, Intravenous; Male; Middle Aged | 1988 |
9 other study(ies) available for fructose-1,6-diphosphate and Coronary Heart Disease
| Article | Year |
|---|---|
[The effect of fructose-1,6-diphosphate and phosphoenolpyruvate on the course of early occlusion and reperfusion arrhythmias in rats].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; Fructosediphosphates; Lidocaine; Myocardial Reperfusion Injury; Phosphoenolpyruvate; Rats; Rats, Wistar | 1993 |
Hemodynamic effects of fructose 1,6-diphosphate in patients with normal and impaired left ventricular function.
Topics: Cardiac Catheterization; Case-Control Studies; Coronary Disease; Energy Metabolism; Female; Fructosediphosphates; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardium; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 1997 |
Role of timing of administration in the cardioprotective effect of fructose-1,6-bisphosphate.
Topics: Adenosine Triphosphate; Animals; Calcium; Coronary Disease; Creatine Kinase; Drug Administration Schedule; Fructosediphosphates; Glutathione; Heart; In Vitro Techniques; Male; Mitochondria, Heart; Myocardial Reperfusion Injury; Norepinephrine; Oxidation-Reduction; Oxygen Consumption; Phosphocreatine; Rabbits; Ventricular Function, Left | 1992 |
[The characteristics of the cardioprotective action of fructose-1,6-diphosphate].
Topics: Acidosis; Animals; Cardiovascular Agents; Coronary Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Fructosediphosphates; Male; Myocardial Infarction; Rabbits; Rats; Time Factors | 1991 |
[Fructose-1,6-diphosphate (FDP) in transitory myocardial ischemia induced by atrial pacing].
Topics: Adult; Aged; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Female; Fructosediphosphates; Hexosediphosphates; Humans; Male; Middle Aged; Placebos | 1988 |
Protective effect of exogenous fructose-1,6-diphosphate in cardiogenic shock.
Topics: Animals; Coronary Disease; Coronary Vessels; Creatine Kinase; Dogs; Electrocardiography; Female; Fructosediphosphates; Hemodynamics; Hexosediphosphates; Isoenzymes; Ligation; Male; Myocardial Infarction; Myocardium; Shock, Cardiogenic; Time Factors | 1988 |
[Improved cardiac performance with fructose-1,6-diphosphate in patients with ischemic heart disease].
Topics: Adult; Aged; Coronary Disease; Exercise Test; Female; Fructosediphosphates; Heart; Hexosediphosphates; Humans; Male; Middle Aged | 1988 |
[Effect of fructose-1,6-diphosphate and trental on the erythrocyte aggregating capacity in ischemic heart disease].
Topics: Adult; Aged; Alcian Blue; Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Erythrocyte Aggregation; Female; Fructosediphosphates; Hexosediphosphates; Humans; Male; Middle Aged; Myocardial Infarction; Pentoxifylline; Theobromine | 1987 |
Hemodynamics and metabolic effects of fructose 1-6 diphosphate in ischemia and shock--experimental and clinical observations.
Topics: Adult; Aged; Animals; Coronary Disease; Dogs; Female; Fructosediphosphates; Hemodynamics; Hexosediphosphates; Humans; Ischemia; Male; Middle Aged; Respiratory Distress Syndrome; Shock | 1986 |